18F-FDG-PET/CT Imaging of Thoracic and Extrathoracic Tuberculosis in Children

Seminars in Nuclear Medicine

Volumn 47, Issue 3, 2017, Pages 304-318

  Pelletier Galarneau, Matthieu ^a,b,c   Martineau, Patrick ^a   Zuckier, Lionel S ^a   Pham, Xuan ^a   Lambert, Raymond ^c   Turpin, Sophie ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL TUBERCULOSIS; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DUAL TIME POINT IMAGING; EXTRATHORACIC TUBERCULOSIS; HEPATOSPLENIC TUBERCULOSIS; HUMAN; IMAGE ANALYSIS; LUNG DISEASE; LYMPHADENOPATHY; MILIARY TUBERCULOSIS; PARENCHYMAL DISEASE; PEDIATRICS; PLEURA EFFUSION; POPULATION; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; REVIEW; THORACIC TUBERCULOSIS; TREATMENT RESPONSE; TUBERCULOSIS; TUBERCULOUS ARTHRITIS; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS OSTEOMYELITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS SPONDYLITIS; CHILD; DIAGNOSTIC IMAGING; THORAX;

CHILD; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; THORAX; TUBERCULOSIS;

EID: 85013159236     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2016.12.003     Document Type: Review

References (103)

1. 1 Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 161 (2000), 1376–1395.
2. 2 Kim, W.S., Choi, J.-I., Cheon, J.-E., et al. Pulmonary tuberculosis in infants: Radiographic and CT Findings. Am J Roentgenol 187 (2006), 1024–1033.
3. 3 Siegel, J.D., Rhinehart, E., Jackson, M., et al. 2007 Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control 35 (2007), S65–S164.
4. 4 WHO, Global tuberculosis report 2016. http://www.who.int/tb/publications/global_report/en/, 2016.
5. 5 WHO, Childhood TB. http://www.who.int/tb/publications/childtbtraining_manual/en/, 2016.
6. 6 Martinson, N.A., Hoffmann, C.J., Chaisson, R.E., Epidemiology of tuberculosis and HIV. Proc Am Thorac Soc 8 (2011), 288–293.
7. 7 Hesseling, A.C., Cotton, M.F., Jennings, T., et al. High incidence of tuberculosis among HIV-infected infants: Evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 48 (2009), 108–114.
8. 8 Seddon, J.A., Shingadia, D., Epidemiology and disease burden of tuberculosis in children: A global perspective. Infect Drug Resist 7 (2014), 153–165.
9. 9 Perez-Velez, C.M., Marais, B.J., Tuberculosis in Children. N Engl J Med 367 (2012), 348–361.
10. 10 Pareek, M., Greenaway, C., Noori, T., et al. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med 14 (2016), 1–10.
11. 11 Morris, S.K., Demers, A.-M., Lam, R., et al. Epidemiology and clinical management of tuberculosis in children in Canada. Paediatr Child Health 20 (2015), 83–88.
12. 12 Pang, J., Teeter, L.D., Katz, D.J., et al. Epidemiology of tuberculosis in young children in the United States. Pediatrics 133 (2014), e494–e504.
13. 13 Marais, B.J., Parker, S.K., Verver, S., et al. Primary and postprimary or reactivation tuberculosis: Time to revise confusing terminology. AJR Am J Roentgenol 192 (2009), W199–W200.
14. 14 Warren, R.M., Victor, T.C., Streicher, E.M., et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med 169 (2004), 610–614.
15. 15 Marx, F.M., Dunbar, R., Enarson, D.A., et al. The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: A retrospective cohort study. Clin Infect Dis 58 (2014), 1676–1683.
16. 18F-FDG-PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J Nucl Med 52 (2011), 880–885.
17. 17 Sathekge, M., Maes, A., Van de Wiele, C., FDG-PET imaging in HIV infection and tuberculosis. Semin Nucl Med 43 (2013), 349–366.
18. 18 Skoura, E., Zumla, A., Bomanji, J., Imaging in tuberculosis. Int J Infect Dis 32 (2015), 87–93.
19. 18F-FDG-PET and PET/CT. Curr Opin Pulm Med 20 (2014), 287–293.
20. 20 Buckner, C.B., Leithiser, R.E., Walker, C.W., et al. The changing epidemiology of tuberculosis and other mycobacterial infections in the United States: Implications for the radiologist. Am J Roentgenol 156 (1991), 255–264.
21. 21 Shingadia, D., Novelli, V., Diagnosis and treatment of tuberculosis in children. Lancet Infect Dis 3 (2003), 624–632.
22. 22 Woodring, J.H., Vandiviere, H.M., Fried, A.M., et al. Update: The radiographic features of pulmonary tuberculosis. AJR Am J Roentgenol 146 (1986), 497–506.
23. 23 Burrill, J., Williams, C.J., Bain, G., et al. Tuberculosis: A radiologic review. Radiographics 27 (2007), 1255–1273.
24. 24 Veedu, P.T., Bhalla, A.S., Vishnubhatla, S., et al. Pediatric vs adult pulmonary tuberculosis: A retrospective computed tomography study. World J Clin Pediatr 2 (2013), 70–76.
25. 25 Leung, A.N., Müller, N.L., Pineda, P.R., et al. Primary tuberculosis in childhood: Radiographic manifestations. Radiology 182 (1992), 87–91.
26. 26 Tomà, P., Lancella, L., Menchini, L., et al. Radiological patterns of childhood thoracic tuberculosis in a developed country: A single institution׳s experience on 217/255 cases. Radiol Med (Torino), 2016; pp 1-13. http://link.springer.com/article/10.1007/s11547-016-0683-9. [Epub ahead of print].
27. 27 Kim, W.S., Moon, W.K., Kim, I.O., et al. Pulmonary tuberculosis in children: Evaluation with CT. AJR Am J Roentgenol 168 (1997), 1005–1009.
28. 28 Boloursaz, M.R., Khalilzadeh, S., Baghaie, N., et al. Radiologic manifestation of pulmonary tuberculosis in children admitted in pediatric ward-Massih Daneshvari Hospital: A 5-year retrospective study. Acta Med Iran 0 (2010), 244–249.
29. 29 Leung, A.N., Pulmonary tuberculosis: The essentials. Radiology 210 (1999), 307–322.
30. 18F-FDG-PET-CT for determination of pulmonary tuberculoma activity. Eur J Nucl Med Mol Imaging 35 (2008), 808–814.
31. 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis. Eur J Nucl Med Mol Imaging 36 (2009), 632–639.
32. 32 Heysell, S.K., Thomas, T.A., Sifri, C.D., et al. 18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: A case series. BMC Pulm Med, 13, 2013, 14.
33. 33 Goo, J.M., Im, J.-G., Do, K.-H., et al. Pulmonary tuberculoma evaluated by means of FDG-PET: Findings in 10 cases. Radiology 216 (2000), 117–121.
34. 34 Harisinghani, M.G., McLoud, T.C., Shepard, J.-A.O., et al. Tuberculosis from head to toe. Radiographics 20 (2000), 449–470.
35. 35 Lee, K.S., Im, J.G., CT in adults with tuberculosis of the chest: Characteristic findings and role in management. AJR Am J Roentgenol 164 (1995), 1361–1367.
36. 36 Mukund, A., Khurana, R., Bhalla, A.S., et al. CT patterns of nodal disease in pediatric chest tuberculosis. World J Radiol 3 (2011), 17–23.
37. 18F-FDG-PET/CT. Clin Nucl Med 39 (2014), 736–737.
38. 38 Ouedraogo, M., Ouedraogo, S.M., Cisse, R., et al. Active tuberculosis in a patient with Hodgkin׳s disease. A case report. Rev Pneumol Clin 56 (2000), 33–35.
39. 39 Sharma, S.K., Mohan, A., Sharma, A., et al. Miliary tuberculosis: New insights into an old disease. Lancet Infect Dis 5 (2005), 415–430.
40. 40 Schaaf, H.S., Gie, R.P., Beyers, N., et al. Tuberculosis in infants less than 3 months of age. Arch Dis Child 69 (1993), 371–374.
41. 41 Vallejo, J.G., Ong, L.T., Starke, J.R., Clinical features, diagnosis, and treatment of tuberculosis in infants. Pediatrics 94 (1994), 1–7.
42. 42 Sharma, S.K., Mohan, A., Sharma, A., Challenges in the diagnosis and treatment of miliary tuberculosis. Indian J Med Res 135 (2012), 703–730.
43. 43 Waagner, D.C., The clinical presentation of tuberculous disease in children. Pediatr Ann 22 (1993), 622–628.
44. 44 Merino, J.M., Carpintero, I., Alvarez, T., et al. Tuberculous pleural effusion in children. Chest 115 (1999), 26–30.
45. 45 Marais, B.J., Gie, R.P., Schaaf, H.S., et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 34 (2004), 886–894.
46. 18F-FDG-PET/CT integrated imaging in distinguishing malignant from benign pleural effusion. PLoS One, 11, 2016, e0161764.
47. 47 Bury, T., Paulus, P., Dowlati, A., et al. Evaluation of pleural diseases with FDG-PET imaging: Preliminary report. Thorax 52 (1997), 187–189.
48. 48 Ceylan, K., Accuracy of 18-FDG-PET/CT in the differential diagnosis of malignant and benign pleural diseases. Int J Hematol Oncol 23 (2013), 124–129.
49. 49 Shinohara, T., Shiota, N., Kume, M., et al. Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma. BMC Infect Dis, 13, 2013, 12.
50. 50 Sharma, S.K., Mohan, A., Extrapulmonary tuberculosis. Indian J Med Res 120 (2004), 316–353.
51. 51 Teo, H.E., Peh, W.C., Skeletal tuberculosis in children. Pediatr Radiol 34 (2004), 853–860.
52. 52 McLain, R.F., Isada, C., Spinal tuberculosis deserves a place on the radar screen. Cleve Clin J Med 71 (2004), 537–539 543–9.
53. 53 Farinha, N.J., Razali, K.A., Holzel, H., et al. Tuberculosis of the central nervous system in children: A 20-year survey. J Infect 41 (2000), 61–68.
54. 54 Lifeso, R.M., Weaver, P., Harder, E.H., Tuberculous spondylitis in adults. J Bone Joint Surg Am 67 (1985), 1405–1413.
55. 55 Prasad, A., Manchanda, S., Sachdev, N., et al. Imaging features of pediatric musculoskeletal tuberculosis. Pediatr Radiol 42 (2012), 1235–1249.
56. 56 Moorthy, S., Prabhu, N.K., Spectrum of MR imaging findings in spinal tuberculosis. AJR Am J Roentgenol 179 (2002), 979–983.
57. 57 Gouliouris, T., Aliyu, S.H., Brown, N.M., Spondylodiscitis: Update on diagnosis and management. J Antimicrob Chemother 65 (2010), iii11–iii24 (suppl 3).
58. 58 De Vuyst, D., Vanhoenacker, F., Gielen, J., et al. Imaging features of musculoskeletal tuberculosis. Eur Radiol 13 (2003), 1809–1819.
59. 59 Rivas-Garcia, A., Sarria-Estrada, S., Torrents-Odin, C., et al. Imaging findings of Pott׳s disease. Eur Spine J 22 (2013), 567–578 (suppl 4).
60. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging 29 (2002), 516–524.
61. 61 Vanhoenacker, F.M., Sanghvi, D.A., De Backer, A.I., Imaging features of extraaxial musculoskeletal tuberculosis. Indian J Radiol Imaging 19 (2009), 176–186.
62. 62 Choi, J.-A., Koh, S.H., Hong, S.-H., et al. Rheumatoid arthritis and tuberculous arthritis: Differentiating MRI features. AJR Am J Roentgenol 193 (2009), 1347–1353.
63. 63 Wang, J.-H., Chi, C.-Y., Lin, K.-H., et al. Tuberculous arthritis—Unexpected extrapulmonary tuberculosis detected by FDG-PET/CT. Clin Nucl Med 38 (2013), e93–e94.
64. 64 Rasool, M.N., Osseous manifestations of tuberculosis in children. J Pediatr Orthop 21 (2001), 749–755.
65. 65 Whiteman, M.L., Neuroimaging of central nervous system tuberculosis in HIV-infected patients. Neuroimaging Clin N Am 7 (1997), 199–214.
66. 66 al-Deeb, S.M., Yaqub, B.A., Sharif, H.S., et al. Neurotuberculosis: A review. Clin Neurol Neurosurg 94 (1992), S30–S33 (suppl).
67. 18F-FDG-PET/CT: Incidentally detected and masquerading as relapse in a patient with ovarian burkitt lymphoma. Clin Nucl Med, 40, 2015, 606–607.
68. 68 Tinsa, F., Essaddam, L., Fitouri, Z., et al. Abdominal tuberculosis in children. J Pediatr Gastroenterol Nutr 50 (2010), 634–638.
69. 69 Cruz, A.T., Starke, J.R., Clinical manifestations of tuberculosis in children. Paediatr Respir Rev 8 (2007), 107–117.
70. 70 Sanai, F.M., Bzeizi, K.I., Systematic review: Tuberculous peritonitis—Presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 22 (2005), 685–700.
71. 71 Chow, K.M., Chow, V.C., Hung, L.C., et al. Tuberculous peritonitis-associated mortality is high among patients waiting for the results of mycobacterial cultures of ascitic fluid samples. Clin Infect Dis 35 (2002), 409–413.
72. 72 Manohar, A., Simjee, A.E., Haffejee, A.A., et al. Symptoms and investigative findings in 145 patients with tuberculous peritonitis diagnosed by peritoneoscopy and biopsy over a five year period. Gut 31 (1990), 1130–1132.
73. 73 Lee, D.H., Lim, J.H., Ko, Y.T., et al. Sonographic findings in tuberculous peritonitis of wet-ascitic type. Clin Radiol 44 (1991), 306–310.
74. 74 Tsujimoto, N., Saraya, T., Takizawa, H., et al. Tuberculous peritonitis incidentally diagnosed on FDG-PET/CT. Intern Med Tokyo Jpn 52 (2013), 841–842.
75. 75 Shimamoto, H., Hamada, K., Higuchi, I., et al. Abdominal tuberculosis: Peritoneal involvement shown by F-18 FDG-PET. Clin Nucl Med 32 (2007), 716–718.
76. 76 Chen, C.-J., Yao, W.-J., Chou, C.-Y., et al. Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT. Ann Nucl Med 22 (2008), 525–527.
77. 77 Mert, A., Ozaras, R., Tabak, F., et al. Localized hepatic tuberculosis. Eur J Intern Med 14 (2003), 511–512.
78. 18F-FDG-PET/CT. Clin Nucl Med 39 (2014), e325–e327.
79. 18F-FDG-PET/CT imaging. Nucl Med Rev 17 (2014), 108–109.
80. 80 Cao, B.-S., Li, X.-L., Li, N., et al. The nodular form of hepatic tuberculosis contrast-enhanced ultrasonographic findings with pathologic correlation. J Ultrasound Med 29 (2010), 881–888.
81. 18F-FDG-PET/CT imaging in a patient with hepatosplenic tuberculosis. Eur J Nucl Med Mol Imaging 37 (2010), 1618–1619.
82. 82 Aaronson, I.A., Urogenital tuberculosis in children. S Afr Med J 71 (1987), 424–426.
83. 83 Kamaleshwaran, K., Shinto, A., Natarajan, S., et al. F-18 FDG-PET/CT in tuberculosis: Non-invasive marker of therapeutic response to antitubercular therapy. Int J Nucl Med Res 2 (2015), 22–24.
84. 18F-FDG-PET/CT imaging identifies bilateral renal tuberculosis in an immunocompromised patient with an unknown primary malignancy. Infect Chemother 47 (2015), 117–119.
85. 18F-FDG-PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 63 (2008), 756–764.
86. 86 Cheng, G., Torigian, D.A., Zhuang, H., et al. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG-PET?. Eur J Nucl Med Mol Imaging 40 (2013), 779–787.
87. 18F-FDG-PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43 (2002), 173–180.
88. 88 Abdul, H., Abdul, N., Nordin, A., Dual time point imaging of FDG-PET/CT in a tuberculous spondylodiscitis. Biomed Imaging Interv J, 6, 2010, e18.
89. 18F-FDG-PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort?. Eur J Nucl Med Mol Imaging 35 (2008), 1305–1315.
90. 90 Harkirat, S., Anana, S., Indrajit, L., et al. Pictorial essay: PET/CT in tuberculosis. Indian J Radiol Imaging 18 (2008), 141–147.
91. 91 Razak, H.R.A., Geso, M., Abdul Rahim, N., et al. Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG-PET/CT. J Med Imaging Radiat Oncol 55 (2011), 556–562.
92. 92 Hofmeyr, A., Lau, W.F., Slavin, M.A., Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberc Edinb Scotl 87 (2007), 459–463.
93. 93 Ichiya, Y., Kuwabara, Y., Sasaki, M., et al. FDG-PET in infectious lesions: The detection and assessment of lesion activity. Ann Nucl Med 10 (1996), 185–191.
94. 94 Kumar, A., Dutta, R., Kannan, U., et al. Evaluation of mediastinal lymph nodes using F-FDG-PET-CT scan and its histopathologic correlation. Ann Thorac Med 6 (2011), 11–16.
95. 95 WHO: Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global report on surveillance and response [Internet]. Available from: http://www.who.int/tb/features_archive/m_xdrtb_facts/en/. Cited April 30, 2015.
96. 96 Gelfand, M.J., Lemen, L.C., PET/CT and SPECT/CT dosimetry in children: The challenge to the pediatric imager. Semin Nucl Med 37 (2007), 391–398.
97. 97 Sathekge, M., Maes, A., D׳Asseler, Y., et al. Tuberculous lymphadenitis: FDG-PET and CT findings in responsive and nonresponsive disease. Eur J Nucl Med Mol Imaging 39 (2012), 1184–1190.
98. 18F-FDG-PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging 42 (2015), 264–271.
99. 99 Tian, G., Xiao, Y., Chen, B., et al. FDG-PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis. Acta Radiol 51 (2010), 1002–1006.
100. 100 Park, I.-N., Ryu, J.-S., Shim, T.S., Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med 33 (2008), 1–3.
101. 18F-FDG-PET/CT in tuberculosis: An early non-invasive marker of therapeutic response. Int J Tuberc Lung Dis 16 (2012), 1180–1185.
102. 18F-FDG-PET-CT as an imaging biomarker for the noninvasive evaluation in uncomplicated skeletal tuberculosis: A prospective clinical observational study. Eur Spine J 23 (2014), 2449–2454.
103. 103 Chen, R.Y., Dodd, L.E., Lee, M., et al. PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci Transl Med, 6, 2014, 265ra166.